StreetInsider.com News Articles

BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'

Wed, 09 Sep 2026 09:26:32 -0400

(Updated - September 9, 2026 9:26 AM EDT)

BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ: TWST) with a Sell rating and a price target of $45.00.

The analyst comments "We are initiating coverage of Twist Biosciences (TWST) with a Sell Rating and $45 target. TWST trades at a significant premium to peers despite operating in a competitive life sciences tools market where integrated incumbents like Danaher (DHR), Agilent Tech. (A), and Roche Holding (RHHBY) exert persistent pricing pressure by bundling NGS capture probes with library prep kits and broad reagent catalogs. The August 2026 stock surge driven by

BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'

Wed, 09 Sep 2026 09:26:32 -0400

(Updated - September 9, 2026 9:26 AM EDT)

BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ: TWST) with a Sell rating and a price target of $45.00.

BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'

Wed, 09 Sep 2026 09:26:32 -0400

(Updated - September 9, 2026 9:26 AM EDT)

BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ: TWST) with a Sell rating and a price target of $45.00.

BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'

Wed, 09 Sep 2026 09:26:32 -0400

(Updated - September 9, 2026 9:26 AM EDT)

BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ: TWST) with a Sell rating and a price target of $45.00.

UBS Assumes Twist Bioscience (TWST) at Neutral

Wed, 09 Sep 2026 06:08:16 -0400

UBS analyst Douglas Schenkel assumes coverage on Twist Bioscience (NASDAQ: TWST) with a Neutral rating and a price target of $144.00.

For an analyst ratings summary and ratings history on Twist Bioscience click here. For more ratings news on Twist Bioscience click here.

Shares of Twist Bioscience closed at $128.06 yesterday.

Twist Bioscience (TWST) PT Raised to $148 at Baird

Thu, 03 Sep 2026 07:06:34 -0400

Baird analyst Catherine Schulte raised the price target on Twist Bioscience (NASDAQ: TWST) to $148.00 (from $115.00) while maintaining a Outperform rating.

Form 4 Twist Bioscience Corp For: Aug 25 Filed by: Leproust Emily M.

Thu, 27 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260827/26989829.html

Form 4 Twist Bioscience Corp For: Aug 25 Filed by: Leproust Emily M.

Thu, 27 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260827/26989829.html

Form 144 Twist Bioscience Corp Filed by: Leproust Emily M.

Tue, 25 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260825/26975577.html

Form 144 Twist Bioscience Corp Filed by: Leproust Emily M.

Tue, 25 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260825/26975577.html

Form 4 Twist Bioscience Corp For: Aug 21 Filed by: Finn Patrick John

Tue, 25 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260825/26974689.html

Form 4 Twist Bioscience Corp For: Aug 21 Filed by: Finn Patrick John

Tue, 25 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260825/26974689.html

Form 4 Twist Bioscience Corp For: Aug 21 Filed by: Leproust Emily M.